We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/10/2020 08:09 | Added twice so far today. This is an absolute steal now. | someuwin | |
22/10/2020 08:09 | Re realist195022 Oct '20 - 08:24 - 12193 "It seems the poor market reaction to both the initial oncology data and latterly the IBS trial results was the final straw. At least it has motivated the team to move quickly and position the business where they clearly know there is considerable investment interest." I don't know realist, seems a little unlikely they cooked this up in the last two weeks after RNS Blautix, looks more like a dobble whammy which might turn out to be a triple or quadruple whammy in the very near future | thresholdbypass | |
22/10/2020 07:57 | Perhaps Seres fell heavily yesterday (see chart in header) because they got wind of the fact that there was a new microbe company coming to NASDAQ to take their crown! | someuwin | |
22/10/2020 07:56 | You are certifiable. | captain james t kirk | |
22/10/2020 07:56 | .....seems like an option for the brain dead at this price;) | thefartingcommie | |
22/10/2020 07:53 | I expect £10 a share by Q1 2021 I expect £100 a share by Q1 2022 | the stigologist | |
22/10/2020 07:53 | Interesting timing by those 2 hedge funds taking out 0.5% and 0.6% shorts in 4D over the last few weeks. A lower share price no doubt helped the US side in this deal. Other than that it looks like a great deal. | loafofbread | |
22/10/2020 07:52 | fantastic news. Forward looking company now. Should get a decent forum again | swallowsflysouth | |
22/10/2020 07:45 | Intro video for US Investors #DDDD $LOAC $LBPS | the stigologist | |
22/10/2020 07:41 | Up to $23 mn in potential warrant proceeds!! Further good news on funding is likely over the coming weeks then. | techtrend | |
22/10/2020 07:40 | blueblood22 Oct '20 - 08:15 - 12179 of 12200 0 0 0 Shows the markets don’t know all the time. £1.10 swap rate when we hit 88p yesterday. .................... A post worth picking out. I agree. And that is another feather in the company's hat. | realist1950 | |
22/10/2020 07:36 | Lots of manipulation going on as we clear the last of the small time flippers! AIM is so fickle. Today's announcement sets 4D on course for a huge re-rate over the coming months.. timing also clearly aligned with the 3 poster presentation in the US. Not to mention the additional £23m in warrant cash and the extra £2m 4D Mmgt have pumped in as part of the merger! A truly Stonking deal | trotterstrading | |
22/10/2020 07:36 | maffs aint my best subject! I do get it; thx Mr Roper. Recon this will tick up over several days as the rns sinks in. | amunro | |
22/10/2020 07:36 | We're still on the cess-pit. A red finish would not be a surprise. | eeza | |
22/10/2020 07:35 | This is a massive opportunity to buy at these low levels. Market hasn't fully grasped the disconnect between 4D and Seres Therapeutics yet. (Clue 4D arguably worth more than Seres even at this stage) | someuwin | |
22/10/2020 07:35 | Myles McNulty @MylesMcNulty · 9m Bought back into #DDDD on the back of today's news of the RTO onto NASDAQ, which I have been waiting for. One need only consider another NASDAQ-listed Live Biotherapeutics Products play, Seres (MCRB) - now at ~$2.5bn mkt cap. US investors are much more liberal! Average ~107p. | showmethemoneyhoney01 | |
22/10/2020 07:31 | Hopefully a proactive interview will be done later. Always gives a good well answered interview does DP. | showmethemoneyhoney01 | |
22/10/2020 07:28 | The Story just begins, now just need a few more of my other stocks to mature quickly so I can pile more into here at anything below £2. Oh well never did get my 80p, but what's 80p or £2 when you're aiming for £75 | katsy | |
22/10/2020 07:24 | Good morning. (GOOD MORNING). I will write a full summary of thoughts on this a little later only to say, for now, this is a very competent BOD - one that has proven it can move quickly and tenaciously within the clinic, and also do the same with regards to its finances and structure. It seems the poor market reaction to both the initial oncology data and latterly the IBS trial results was the final straw. At least it has motivated the team to move quickly and position the business where they clearly know there is considerable investment interest. As I have posted previously, there is a good level of expertise here in both camps....that of 'money men' - those who are at just the right age/experience and possess good levels of drive and energy, (AND who are very much invested), and, expertise - SECTOR LEADING expertise no less - within the actual clinic. It's a very nicely balanced company. It seems to be so utterly lost on many over the past few days that this company is highly likely to announce something of great significance next month at the conference regarding oncology.....not to mention a likely partnering deal for Blautix before the end of the year. I was pleased to add a fairly thick wad of shares yesterday....althoug Hugely encouraging. Rgds. | realist1950 | |
22/10/2020 07:24 | Gbp:usd fx rate and also where the stock issued on aim and nasdaq are same quantity. Doubtful they will be so it could be 1 nasdaq adr = 10 aim shares. Then you do the maffs | mr roper | |
22/10/2020 07:23 | 4D are operating in an new and rapidly emerging therapeutic area and there's no doubt that the US markets embrace new technology much more readily, so a nasdaq listing makes sense. Having the Merck deal and collaboration under their belts will give 4D extra visibility too. Good stuff. Love the ticker - LBPS (live biotherapeutics) | bermudashorts | |
22/10/2020 07:21 | I am interested in how an aim price will track a nasdaq price. Anyone any experience on this? | amunro | |
22/10/2020 07:19 | Now in Nasdaq should hit 160.0 soon | bag158s |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions